SEARCH IN BRIEF

 
Dempsey joins Nightingale

Leading science architect, Paul Dempsey, is to join Nightingale Associates as the new board-level Science Development Director this month.

Specialising in the pharmaceutical and science sector, Dempsey previously worked for CBRE, Pfizer and Bovis Lend Lease Pharmaceutical. His addition to Nightingale Associates, a leading architectural practice specialising in health, education and science buildings, aims to build upon the practice’s accomplishments within the science sector, helping to promote the company’s knowledge and innovation.

Dempsey said: “I am delighted to be joining Nightingale Associates to help further expand the excellent track record it already has in the science sector. My appointment is intended to boost the science capability with our existing clients and to help develop future work in new and exciting industry sectors.”

Dempsey was recognised as a pioneer and leader of ‘Lab of the Future’ projects, was awarded the prestigious William E Upjohn prize for innovation, and was the first non-scientist award winner in Pfizer’s history for his influential role on the Pfizer FlexiLab projects.

Starting in mid-September Dempsey will be based in Nightingale Associates’ London office.

IN BRIEF
Wednesday 16 September 2009
Faculty member Hernan Diaz Alonso announced as the next Director of SCI-Arc
Fri 19 Sep 2014
East County Hall of Justice breaks ground in Dublin
Fri 19 Sep 2014
Mott MacDonald acquires Bentley Holdings
Fri 19 Sep 2014
Shedkm receives planning for Circus Street scheme
Thu 18 Sep 2014
Writers Theatre in Illinois to break ground in October
Thu 18 Sep 2014
WAN Civic Buildings Award winners revealed in Amsterdam
Fri 12 Sep 2014
Chris van Duijn, Ippolito Pestellini Laparelli, Jason Long and Michael Kokora promoted to partner at OMA
Wed 10 Sep 2014
Groundbreaking held for Johnson Fain-designed residential towers in Jakarta
Wed 10 Sep 2014